Reduced Helper (OKT4+): Suppressor (OKT8+) T Ratios in Aplastic Anaemia: Relation to Immunosuppressive Therapy
Overview
Affiliations
T cell subset composition of peripheral blood and bone marrow from 22 patients with aplastic anaemia (AA) was studied by monoclonal antibodies (OKT3, OKT4 and OKT8). In the peripheral blood, OKT3 (pan-T), OKT4 (helper/inducer-T) and OKT8 (suppressor-T) cells varied widely in number. The ratios of OKT4:OKT8 exhibited the same tendency. However, a subgroup of AA with a reduced ratio of lower than 1.0 was present both in cases with or without prior prednisolone therapy. Of the eight patients treated with immunosuppressants, four with reduced ratios responded, whereas the other four with normal or higher ratios did not. The ratios of two of four responders gradually reached the normal level. These results suggest that the reduced OKT4:OKT8 ratio may be related to the cell-mediated immunosuppressive mechanism postulated as a cause of stem cell inhibition in a subgroup of AA, and indicate prospectively the effectiveness of immunosuppressive therapy.
Very severe aplastic anemia appearing after thymectomy.
Park C, Kim H, Kim Y, Park Y, Lee J, Min W Korean J Intern Med. 2003; 18(1):61-3.
PMID: 12760272 PMC: 4531598. DOI: 10.3904/kjim.2003.18.1.61.
Immune suppression therapy in aplastic anemia: influencing factors on response and survival.
Jin J, Kim D, Lee J, Han C, Min W, Park C Korean J Intern Med. 1995; 10(1):25-31.
PMID: 7626553 PMC: 4532026. DOI: 10.3904/kjim.1995.10.1.25.
Falcao R, Voltarelli J, Bottura C Blut. 1985; 50(2):103-7.
PMID: 3871647 DOI: 10.1007/BF00321173.
Koller U, Hinterberger W, Gschwandtler L, Grumayer R, Majdic O, Knapp W Blut. 1989; 58(1):21-6.
PMID: 2521803 DOI: 10.1007/BF00320231.
Immunomodulation therapy for severe aplastic anemia--ALG versus ALG plus cyclosporin A.
Park C, Han C, Kim C, Kim D, Kim H Korean J Intern Med. 1989; 4(1):28-33.
PMID: 2487402 PMC: 4534967. DOI: 10.3904/kjim.1989.4.1.28.